BioAtla, Inc. Stockholders Equity

Quick Answer

BioAtla, Inc. reported Stockholders Equity of -$36.19 million for fiscal year 2025.

BioAtla, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 -$36.19M -353.7%
2024 $14.27M -79.8%
2023 $70.67M -60.8%
2022 $180.34M -14.5%
2021 $210.82M +0.4%
2020 $209.97M +474.9%
2019 -$56.01M -96.9%
2018 -$28.45M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$31.24M -236.0% -86.5%
June 30, 2025 -$16.75M -153.4% -3161.2%
March 31, 2025 $547.0K -98.9% -96.2%
December 31, 2024 $14.27M -79.8% -37.9%
September 30, 2024 $22.97M -75.7% -26.8%
June 30, 2024 $31.37M -74.8% -36.9%
March 31, 2024 $49.72M -68.2% -29.7%
December 31, 2023 $70.67M -60.8% -25.4%
  • BioAtla, Inc. showed a decrease of -353.7% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2018–2025 period, BioAtla, Inc.’s stockholders equity has declined by 27.2% (from -$28.45 million to -$36.19 million).
  • The most recent figure is from BioAtla, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment